Marinus Pharmaceuticals reported $10.97M in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
ALKERMES ALKS:US 294.07M 632K
Amgen AMGN:US $ 28458M 2671M
Aptinyx Inc APTX:US $ 0 0
Arena Pharmaceuticals ARNA:US $ 38.78M 1.25M
Biogen BIIB:US $ 7269.2M 2M
Eisai 4523:JP Y 49913M 5M
Esperion Therapeutics ESPR:US $ 272.1M 404K
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 10.97M 10.97M
Minerva Neurosciences NERV:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Ptc Therapeutics PTCT:US $ 1115.38M 3.45M
Regeneron Pharmaceuticals REGN:US $ 1979.2M 0.3M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Supernus Pharmaceuticals SUPN:US $ 370.38M 14.15M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
YTE INCY:US $ 31.84M 0.32M
Zogenix ZGNX:US $ 153.63M 2.18M